Cited by 120Cardiac Arrhythmias and TreatmentsCardiac electrophysiology and arrhythmiasCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

Crijns, Harry J., van Gelder, Isabelle C., Lie, K.I.·1988·The American Journal of Cardiology

DOI 10.1016/0002-9149(88)90282-2

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0002-9149(88)90282-2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex
Wellens, H. J. J., Bär, F. W. H. M., & Lie, K. I. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90176-6 · Cited by 538
Self-citation
Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers
Ikeda, N., Singh, B. N., Davis, L. D., & Hauswirth, O. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80051-6 · Cited by 97

Show all 2 references

Sorted by citations

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citation
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,362
Self-citation
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,161
Self-citation
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Huezey, J.-Y. L., Lowe, J. E., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.013 · Cited by 928
Self-citation
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Kay, G. N., Le Huezey, J.-Y., Lowe, J. E., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318214876d · Cited by 859
Self-citation
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · EP Europace · doi:10.1093/europace/eul108 · Cited by 741
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 777
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · EP Europace · doi:10.1093/europace/eul097 · Cited by 670
Self-citation
Management of Patients With Atrial Fibrillation
Prystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 638
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary
Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 646
Self-citation
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 644
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Circulation · doi:10.1161/circ.104.17.2118 · Cited by 607
Self-citation
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2983 · Cited by 491
Self-citation
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.018 · Cited by 468
Self-citation
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177031 · Cited by 345
Self-citation
Management of Atrial Fibrillation
Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 322
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter
Crijns, H. J. G. M., Gelder, I. C. V., van Gilst, W. H., Hillege, H. L., Gosselink, A. M., & Lie, K. I. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90828-9 · Cited by 275
Self-citation
Rate control in atrial fibrillation
Gelder, I. C. V., Rienstra, M., Crijns, H. J. G. M., & Olshansky, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31258-2 · Cited by 212
Self-citation
Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter
Gelder, I. C. V., Crijns, H. J. G. M., van Gilst, W. H., van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187
Self-citation
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188
Self-citation
Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter
Falk, R. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-141 · Cited by 184
Flecainide-Induced Ventricular Tachycardia and Fibrillation in Patients Treated for Atrial Fibrillation
Falk, R. H. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-2-107 · Cited by 183
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
Naccarelli, G. V., Wolbrette, D. L., Khan, M. R., Bhatta, L., Hynes, J. K., Samii, S. M., & Luck, J. C. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03375-1 · Cited by 172
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
Aliot, E., Capucci, A., Crijns, H. J. G. M., Goette, A., & Tamargo, J. L. (2010) · EP Europace · doi:10.1093/europace/euq382 · Cited by 168
Self-citation
Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs
Feld, G. K., Chen, P., NICOD, P. H., FLECK, R. P., & Meyer, D. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90856-v · Cited by 147
Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter
Naccarelli, G. V., Dorian, P., Hohnloser, S. H., & Coumel, P. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89118-7 · Cited by 134
Mechanisms and management of proarrhythmia
Roden, D. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00472-x · Cited by 127
Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.
Gelder, I. C. V., Hagens, V. E., Kingma, J. H., Bosker, H. A., Otto Kamp, B., Kingma, T., Veeger, N. J. G. M., Bouma, J., TenVergert, E. M., Tijssen, J. G. P., et al. (2002) · PubMed Central · Cited by 125
Self-citation
Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
Brandes, A., Crijns, H. J. G. M., Rienstra, M., Kirchhof, P. F., Grove, E. L., Pedersen, K. B., & Gelder, I. C. V. (2020) · EP Europace · doi:10.1093/europace/euaa057 · Cited by 139
Self-citation
Atrial flutter in patients treated for atrial fibrillation with propafenone
Murdock, C. J., Kyles, A. E., Yeung-Lai-Wah, J. A., Qi, A., Vorderbrugge, S., & Kerr, C. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91144-u · Cited by 114
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation
Pritchett, E. L. C., Page, R. L., Carlson, M. D., Undesser, K. P., & Fava, G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00974-3 · Cited by 105
Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response
Pritchett, E. L. C., Page, R. L., Connolly, S. J., Marcello, S. R., Schnell, D., & Wilkinson, W. E. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00773-7 · Cited by 102
Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation
Schumacher, B. M., Jung, W., Lewalter, T., Vahlhaus, C., Wolpert, C., & Lüderitz, B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00975-8 · Cited by 101
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology
Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 112
Self-citation
Diagnostic criteria of broad QRS complex tachycardia: decades of evolution
Alzand, B. S. N., & Crijns, H. J. G. M. (2011) · Europace · doi:10.1093/europace/euq430 · Cited by 93
Self-citation
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens
Botto, G. L., Capucci, A., Bonini, W., Boriani, G., BROFFONI, T., Barone, P., Espureo, M., Lombardi, R., Molteni, S., & Ferrari, G. M. (1997) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02841-0 · Cited by 77
Proarrhythmia
Friedman, P. L., & Stevenson, W. G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00586-4 · Cited by 70
Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation
Blanc, J., Voinov, C., & Maarek, M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00493-2 · Cited by 69
Antiarrhythmic drugs: from mechanisms to clinical practice
Roden, D. M. (2000) · Heart · doi:10.1136/heart.84.3.339 · Cited by 58
Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias
Brembilla-Perrot, B., Houriez, P., Beurrier, D., Claudon, O., Chaise, A. T. D. L., & Louis, P. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00459-4 · Cited by 56
Regular Ventricular Rhythms Before Conversion of Recent Onset Atrial Fibrillation to Sinus Rhythm
Botto, G., Bonini, W., BROFFONI, T., CAPPELLETTI, G. A., Falcone, C., LOMBARDI, R., Paulesu, A., PEDRAGLIO, E., & Ferrari, G. M. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb03810.x · Cited by 56
Clinical Pharmacokinetics of Propafenone
Hii, J. T. Y., Duff, H. J., & Burgess, E. D. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121010-00001 · Cited by 55
Pharmacology and Toxicology of Nav1.5-Class 1 Antiarrhythmic Drugs
Roden, D. M. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2014.07.003 · Cited by 48
Flecainide Toxicity: A Case Report and Systematic Review of its Electrocardiographic Patterns and Management
Valentino, M. A., Panakos, A., Ragupathi, L., Williams, J. L., & Pavri, B. B. (2016) · Cardiovascular Toxicology · doi:10.1007/s12012-016-9380-0 · Cited by 47
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation31This document was approved by the American College of Cardiology Board of Trustees in August 2001, the American Heart Association Science Advisory and Coordinating Committee in August 2001, and the European Society of Cardiology Board and Committee for Practice Guidelines and Policy Conferences in August 2001.32When citing this document, the American College of Cardiology, the American Heart Association, and the European Society of Cardiology would appreciate the following citation format: Fuster V, Rydén LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Lévy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2001;38:XX-XX.33This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (www.americanheart.org), the European Society of Cardiology (www.escardio.org), and the North American Society of Pacing and Electrophysiology (www.naspe.org). Single reprints of this document (the complete Guidelines) to be published in the mid-October issue of the European Heart Journal are available by calling +44.207.424.4200 or +44.207.424.4389, faxing +44.207.424.4433, or writing Harcourt Publishers Ltd, European Heart Journal, ESC Guidelines – Reprints, 32 Jamestown Road, London, NW1 7BY, United Kingdom. Single reprints of the shorter version (Executive Summary and Summary of Recommendations) published in the October issue of the Journal of the American College of Cardiology and the October issue of Circulation, are available for $5.00 each by calling 800-253-4636 (US only) or by writing the Resource Center, American College of Cardiology, 9111 Old Georgetown Road, Bethesda, Maryland 20814. To purchase bulk reprints specify version and reprint number (Executive Summary 71-0208; full text 71-0209) up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342; or E-mail: pubauth@heart.org.
Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01586-8 · Cited by 47
Self-citation
Conversion of Recent Onset Atrial Fibrillation with Single Loading Oral Dose of Propafenone: Is In‐Hospital Admission Absolutely Necessary?
Botto, G. L., Bonini, W., BROFFONI, T., Molteni, S., LOMBARDI, R., ALFIERI, G., Barone, P., Bernasconi, G., & Ferrari, G. M. (1996) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1996.tb03257.x · Cited by 44
Flecainide
Falk, R. H., & Fogel, R. I. (1994) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1994.tb01136.x · Cited by 39
Antiarrhythmic Drug Therapy in the Management of Atrial Fibrillation
Ganz, L. I., & Antman, E. M. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb01005.x · Cited by 38
Approach to the Diagnosis and Initial Management of the Stable Adult Patient With a Wide Complex Tachycardia
Goldberger, Z. D., Rho, R. W., & Page, R. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.024 · Cited by 34
Proarrhythmia
Roden, D. M., & Anderson, M. E. (2006) · Springer eBooks · doi:10.1007/3-540-29715-4_3 · Cited by 31
Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs
Kawabata, M., Hirao, K., Horikawa, T., Suzuki, K., Motokawa, K., Suzuki, F., Azegami, K., & Hiejima, K. (2001) · Journal of Electrocardiology · doi:10.1054/jelc.2001.22034 · Cited by 29
Is There a Future for Antiarrhythmic Drug Therapy?
Guerra, P. G., Talajic, M. R., Roy, D., Dubuc, M., Thibault, B., & Nattel, S. (1998) · Drugs · doi:10.2165/00003495-199856050-00003 · Cited by 25
Effect of Drugs on the Electrocardiogram
(2008) · Elsevier eBooks · doi:10.1016/b978-141603774-3.10021-8 · Cited by 26
Adverse Effects of Class I Antiarrhythmic Drugs
Caron, J., & Libersa, C. (1997) · Drug Safety · doi:10.2165/00002018-199717010-00002 · Cited by 25
Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias
Lavalle, C., Magnocavallo, M., Straito, M., Santini, L., Forleo, G. B., Grimaldi, M., Badagliacca, R., Lanata, L., & Ricci, R. P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071456 · Cited by 24
Antiarrhythmic Drugs:
Roden, D. M. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03441.x · Cited by 23
Regular ventricular rhythms in patients with symptomatic paroxysmal atrial fibrillation
Weiner, H. L., McCarthy, E. A., & Pritchett, E. L. C. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80136-6 · Cited by 23
Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives
Lavalle, C., Trivigno, S., Vetta, G., Magnocavallo, M., Mariani, M. V., Santini, L., Forleo, G. B., Grimaldi, M., Badagliacca, R., Lanata, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163696 · Cited by 22
ACC/AHA/ESC: Guías de Práctica Clínica 2006 para el manejo de pacientes con fibrilación auricular. Versión resumida
Informe del Grupo de Trabajo para la elaboración de guías de práctica clínica del American College of Cardiology y de la American Heart Association, del Comité de Guías de Práctica Clínica de la Sociedad Europea de Cardiología (comité de redacción para la revisión de la Guía de práctica clínica sobre el manejo de pacientes con fibrilación auricular, 2., & Desarrollado en colaboración con las asociaciones European Heart Rhythm Association y Heart Rhythm Society (2006) · Revista Española de Cardiología · doi:10.1157/13096583 · Cited by 20
Torsade-de-pointes in a patient under flecainide treatment, an unusual case of proarrhythmicity
Nogales‐Asensio, J. M., Sánchez, N. M., Doncel-Vecino, L. J., Mariscal, C. V., López-Mínguez, J. R., & Herrera, A. M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.124 · Cited by 19
Is There a Role for Maintaining Sinus Rhythm in Patients with Atrial Fibrillation?
ZIMETBAUM, P. J., & Josephson, M. E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00015 · Cited by 19
Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses
Carstensen, H., Hesselkilde, E. M., Fenner, M. F., Loft‐Andersen, A. V., Flethøj, M., Kanters, J. K., Sattler, S. M., Tfelt‐Hansen, J., Pehrson, S. M., Jespersen, T., et al. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15287 · Cited by 18
THE MEDICAL MANAGEMENT OF ATRIAL FIBRILLATION
Masoudi, F. A., & Goldschlager, N. (1997) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70370-2 · Cited by 17
Antiarrhythmic drug initiation in patients with atrial fibrillation
Pinski, S. L., & Helguera, M. E. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70010-1 · Cited by 14
Atrial fibrillation: New management strategies
Pai, S. M., & Torres, V. I. (1993) · Current Problems in Cardiology · doi:10.1016/0146-2806(93)90024-v · Cited by 14
Safety and Efficacy of Oral Flecainide Acetate in Patients with Cardiac Arrhythmias.
Nakazato, Y., Nakata, Y., Yasuda, M., Nakazato, K., Sumiyoshi, M., Ogura, S., & Yamaguchi, H. (1997) · Japanese Heart Journal · doi:10.1536/ihj.38.379 · Cited by 13
Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study
Er, F., Aslan, O., Caglayan, E., Gassanov, N., Nia, A. M., Erdmann, E., & Rosenkranz, S. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0129-7 · Cited by 12
Atrial Fibrillation and Flutter
Brady, P. A., & Gersh, B. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_95 · Cited by 12
Oral antiarrhythmic drugs in converting recent onset atrial fibrillation
Deneer, V. H. M., Borgh, M. B. I., Kingma, J. H., Lie‐A‐Huen, L., & Brouwers, J. R. B. J. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000018593.02291.c0 · Cited by 12
Flecainide Induced Atrial Tachycardia with 1:1 Ventricular Conduction During Exercise Testing
Randazzo, D. N., Schweitzer, P., STEIN, E., Banas, J. S., & Winters, S. L. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01516.x · Cited by 12
Antiarrhythmic drug treatment: need for continuous vigilance.
Wellens, H. J. J., Smeets, J. L. R. M., Vos, M. A., & Gorgels, A. P. M. (1992) · Heart · doi:10.1136/hrt.67.1.25 · Cited by 12
Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks
Loomba, R. S., Singh, A. K., Kovach, J. R., & Gudausky, T. M. (2014) · Cardiology in the Young · doi:10.1017/s1047951114001188 · Cited by 11
AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING)
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. Y. L., Kay, G. N., Lowe, J. E., et al. (2007) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2007-3-3-84-111 · Cited by 11
Self-citation
Right bundle branch block–type wide QRS complex tachycardia with a reversed R/S complex in lead V6: Development and validation of electrocardiographic differentiation criteria
Kim, M., Kwon, C. H., Lee, J. H., Hwang, K. W., Choi, H. O., Kim, Y., Lee, K., Ahn, J., Park, H., & Nam, G. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.08.023 · Cited by 10
Limitations of the negative concordance pattern in the diagnosis of broad QRS tachycardia
Barold, S. S., Stroobandt, R. X., & Herweg, B. (2012) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2012.06.017 · Cited by 9
Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation
Limantoro, I., de Vos, C. B., Delhaas, T., Marcos, E. G., Blaauw, Y., Weijs, B., Tieleman, R. G., Pisters, R., Schotten, U., Gelder, I. C. V., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.12.010 · Cited by 8
Self-citation
Complex Arrhythmias Due to Reversible Causes
Pozzolini, A., Rio, T., Padeletti, M., Ponti, R. D., Leonelli, F. M., & Bagliani, G. (2019) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2019.03.002 · Cited by 8
Wide Complex Tachycardia in the Presence of Class I Antiarrhythmic Agents: A Diagnostic Challenge
Bhardwaj, B., Lazzara, R., & Stavrakis, S. (2013) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12099 · Cited by 8
Bedside Diagnosis of Wide QRS Tachycardia
Barold, S. S. (1995) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1995.tb04634.x · Cited by 8
Long‐term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide‐induced atrial flutter
Hirao, K., Okishige, K., Yamamoto, N., Otomo, K., Azegami, K., & Isobe, M. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280707 · Cited by 7
Class I Antiarrhythmic Drugs: Na+ Channel Blockers
Shenasa, M., Shenasa, M.-A., & Smith, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-34893-9_2 · Cited by 6
Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion
Colangelo, T., Johnson, D. M., & Ho, R. T. (2021) · Texas Heart Institute Journal · doi:10.14503/thij-19-7099 · Cited by 6
Antiarrhythmic Drugs
Roden, D. M., Darbar, D., & Kannankeril, P. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_102 · Cited by 6
Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: Ventricular or supraventricular proarrhythmia?
Wiesfeld, A. C. P., Ansink, J. M., van Veldhuisen, D. J., & Gelder, I. C. V. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.01.033 · Cited by 6
Positive inotropic drugs and drugs used in dysrhythmias
Aronson, J. K. (2004) · Side effects of drugs annual · doi:10.1016/s0378-6080(04)80024-2 · Cited by 6
Characteristics of Patients with Chronic Atrial Fibrillation and the Prediction of Successful DC Electrical Cardioversion
Gelder, I. C. V., Crijns, H. J. G. M., & Lie, K. I. (1992) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1816-3_5 · Cited by 6
Self-citation
Ambient pollutants as adjuvant for allergic sensitization: the emerging role of platinum group elements.
Burastero, S. E., Paolucci, C., & Fabbri, M. (2009) · PubMed · Cited by 6
Rhythm Association and the Heart Rhythm Society Developed in Collaboration With the European Heart Atrial Fibrillation): Committee to Revise the 2001 Guidelines for the Management of Patients With the European Society of Cardiology Committee for Practice Guidelines (Writing Cardiology/American Heart Association Task Force on Practice Guidelines and Fibrillation—Executive Summary: A Report of the American College of ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial
Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, L., Despres, C., Dickstein, K., Lekakis, J. P., McGregor, K., Metra, M., Budaj, A., et al. (2006) · Cited by 5
Self-citation
Antiarrhythmic Drugs:
Roden, D. M. (2003) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2003.00375.x · Cited by 5
Еlectrocardiographic criteria and algorithms for differential diagnosis of wide QRS complexes arrhythmias
Budanova, M. A., Chmelevsky, M. P., Treshkur, T. V., & Тихоненко, В. М. (2021) · Journal of Arrhythmology · doi:10.35336/va-2020-4-24-32 · Cited by 3
Supraventricular Tachycardia: Electrocardiogram Diagnosis and Clinical Management for the Non-electrophysiologist
Boehmer, A. A., Rothe, M., Soether, C. M., Kaess, B. M., & Ehrlich, J. R. (2021) · European Journal of Arrhythmia & Electrophysiology · doi:10.17925/ejae.2021.7.1.4 · Cited by 3
The World of Pacing and Electropysiology: Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation
Saskena, S., DOMANSKI, M. J., Benjamin, E. J., Camm, A. J., Ezekowitz, M. D., Gersh, B. J., Jalife, J., Naccarelli, G. V., Vlietstra, R. E., & Wyse, D. G. (2001) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1011489306778 · Cited by 3
Plasma viscosity, fibrinogen, white cell count, and cardiovascular risk factors.
Jay, R. H., RAMPLING, M. W., & Betteridge, D. J. (1992) · Circulation · doi:10.1161/circ.85.5.1572057 · Cited by 3
Drug Effects on ECGs
Bonelli, P., Giannini, I., Matassini, M. V., & Menditto, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-91677-4_13 · Cited by 2
Fibrinogen, viscosity, and white blood cell count.
Ernst, E. (1992) · Circulation · doi:10.1161/circ.85.5.1572056 · Cited by 2
Diagnóstico diferencial de las taquicardias de complejo ancho: un desafío permanente
René Asenjo, G., Morris, R., Sanhueza, E. J., Ortiz, M. A., & Cereceda, M. (2020) · Revista chilena de cardiología · doi:10.4067/s0718-85602020000100055 · Cited by 2
Maintaining stability of sinus rhythm in atrial fibrillation: Antiarrhythmic drugs versus ablation
Naccarelli, G. V., Hynes, J. K., Wolbrette, D. L., Bhatta, L., Khan, M. R., & Luck, J. C. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0042-4 · Cited by 2
In-Hospital Approach to Newly Recognized Atrial Fibrillation
Kimmelstiel, C. D., Homoud, M. K., Clyne, C. A., & Estes, M. (1999) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008825318341 · Cited by 1

Authors: Crijns, H. J., van Gelder, I. C., & Lie, K. I.
Affiliations: University Medical Center Groningen (NL)
ORCID: Crijns, Harry J.
Lie, K.I.
Venue: The American Journal of Cardiology
Publisher: Elsevier BV
Published: 1988-12
Volume: 62
Issue: 17
Pages: 1303-1306
ISSN: 0002-9149 (ISSN-L)
DOI: 10.1016/0002-9149(88)90282-2
OpenAlex: W2033232925
Cited by: 120
References: 2
Citations by year: 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2021: 7 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2014: 2 · 2013: 3 · 2012: 4
FWCI: 2.86
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The American Journal of Cardiology (publishedVersion)
PubMed (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: supraventricular tachycardia, flecainide, wide complex tachycardia, QRS widening, class Ic antiarrhythmic drugs, bundle branch block
MeSH terms: Aged, Bundle-Branch Block, Electrocardiography, Female, Flecainide, Humans, Male, Middle Aged, Tachycardia, Tachycardia, Supraventricular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks